BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 12804177)

  • 1. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
    Proulx C; Boyer L; Hurnanen DR; Lemieux R
    J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.
    De Bruyn C; Delforge A; Martiat P; Bron D
    Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
    Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
    Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells.
    Halle P; Rouzier C; Kanold J; Boiret N; Rapatel C; Mareynat G; Tchirkov A; Berger M; Travade P; Bonhomme J; Deméocq F
    Ann Hematol; 2000 Jan; 79(1):13-9. PubMed ID: 10663616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood.
    Su RJ; Li K; Yang M; Zhang XB; Tsang KS; Fok TF; Li CK; Yuen PM
    Bone Marrow Transplant; 2001 May; 27(10):1075-80. PubMed ID: 11438824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
    Shaw PH; Olszewski M; Kletzel M
    J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro expansion and function of cord blood megakaryocyte].
    Ju XL; Shi Q; Huang ZW; Hou HS; Sun NZ; Zhao Y; Shen BJ
    Zhonghua Er Ke Za Zhi; 2007 Jan; 45(1):64-8. PubMed ID: 17349156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution.
    Bruno S; Gunetti M; Gammaitoni L; Danè A; Cavalloni G; Sanavio F; Fagioli F; Aglietta M; Piacibello W
    Haematologica; 2003 Apr; 88(4):379-87. PubMed ID: 12681964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of early and late megakaryocyte progenitors.
    Lefebvre P; Winter JN; Meng Y; Cohen I
    J Hematother Stem Cell Res; 2000 Dec; 9(6):913-21. PubMed ID: 11177605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Difference in ex vivo expansion of megakaryocytes derived from umbilical cord blood and peripheral blood].
    Fang JP; Xia T; Chen GH; Wu YF; Xu HG; Wei J; Huang SL
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):869-72. PubMed ID: 17274882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
    Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
    Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin is synergistic with other cytokines for expansion of cord blood progenitor cells.
    Won JH; Cho SD; Park SK; Lee GT; Baick SH; Suh WS; Hong DS; Park HS
    J Hematother Stem Cell Res; 2000 Aug; 9(4):465-73. PubMed ID: 10982244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine prolactin-like protein E synergizes with human thrombopoietin to stimulate expansion of human megakaryocytes and their precursors.
    Lefebvre P; Lin J; Linzer DI; Cohen I
    Exp Hematol; 2001 Jan; 29(1):51-8. PubMed ID: 11164105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors.
    Li K; Yang M; Lam AC; Yau FW; Yuen PM
    Cell Transplant; 2000; 9(1):125-31. PubMed ID: 10784074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ex vivo expansion of megakaryocyte progenitor cells from human cord blood in serum-free culture].
    Mo WJ; Mao P; He QS; Ying Y; Zhu ZG; Xiu YL; Du QH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):133-7. PubMed ID: 15157318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling.
    Sui X; Tsuji K; Ebihara Y; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
    Blood; 1999 Apr; 93(8):2525-32. PubMed ID: 10194431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.